Tolerance of spironolactoneHUGHES, B. R; CUNLIFFE, W. J.British journal of dermatology (1951). 1988, Vol 118, Num 5, pp 687-691, issn 0007-0963Article

Long-term treatment with antiandrogensRASMUSSEN, F.Journal of steroid biochemistry and molecular biology. 1990, Vol 37, Num 6, pp 917-919, issn 0960-0760, 3 p.Conference Paper

A randomized-double-blind study evaluating anandron® associated with orchiectomy in stage D prostate cancerNAMER, M; TOUBOL, J; CATY, A et al.Journal of steroid biochemistry and molecular biology. 1990, Vol 37, Num 6, pp 909-915, issn 0960-0760, 7 p.Conference Paper

Dicofol degradation to p,p'-dichlorobenzophenone - A potential antiandrogenTHIEL, Anette; GUTH, Sabine; BÖHM, Sonja et al.Toxicology (Amsterdam). 2011, Vol 282, Num 3, pp 88-93, issn 0300-483X, 6 p.Article

Flutamine as primary treatment for metastatic prostatic cancerLUNDGREN, R.British journal of urology (Print). 1987, Vol 59, Num 2, pp 156-158, issn 0007-1331Article

Sensitive in vitro test systems to determine androgenic/antiandrogenic activityGUTH, Sabine E; BÖHM, Sonja; MUSSLER, Bernd H et al.Molecular nutrition & food research (Print). 2004, Vol 48, Num 4, pp 282-291, issn 1613-4125, 10 p.Article

Traitement de l'hirsutisme idiopathique par la spironolactone = Treatment of idiopathic hirsutism by spironolactoneSCHLIENGER, J. L; SAPIN, R.Revue française d'endocrinologie clinique, nutrition et métabolisme. 1985, Vol 26, Num 3, pp 257-260, issn 0048-8062Article

Anti-androgenic activity of 3-methyl-4-nitrophenol in diesel exhaust particlesCHUNMEI LI; TANEDA, Shinji; SUZUKI, Akira K et al.European journal of pharmacology. 2006, Vol 543, Num 1-3, pp 194-199, issn 0014-2999, 6 p.Article

The antiandrogen cyproterone acetate: discovery, chemistry, basic pharmacology, clinical use and tool in basic researchNEUMANN, F.Experimental and clinical endocrinology. 1994, Vol 102, Num 1, pp 1-32, issn 0232-7384Article

Mifepristone : separating fact from fictionHENSHAW, R. C; TEMPLETON, A. A.Current therapeutics. 1992, Vol 33, Num 12, pp 17-20, issn 0311-905XArticle

Spironolactone in dermatologic therapySHAW, J. C.Journal of the American Academy of Dermatology. 1991, Vol 24, Num 2, pp 236-243, issn 0190-9622, 8 p., p.1Article

Ein wirksames topisches Antiandrogen: 17α-Propylmesterolon ― bei Akne = Un antiandrogène actif localement: 17α-propylmestérolone, dans l'acné = A topically active antiandrogen: 17α-propylmesterolone, in acneSCHMIDT, J. B; SPONA, J.Hautarzt. 1987, Vol 38, Num 8, pp 470-473, issn 0017-8470Article

Effet anti-séborrhéique de la cimétidine = Antiandrogen effect of cimetidineCARON, P; CHATEAUNEUF, C; BAZEX, J et al.Biomedicine & pharmacotherapy. 1987, Vol 41, Num 5, pp 253-254, issn 0753-3322Article

Effects of flutamide on testicular involution induced by an antagonist of gonadotrophin-releasing hormone and on stimulation of spermatogenesis by follicle-stimulating hormone in ratsCHANDOLIA, R. K; WEINBAUER, G. F; FINGSCHEIDT, U et al.Journal of reproduction and fertility. 1991, Vol 93, Num 2, pp 313-323, issn 0022-4251Article

Synthesis of 11α-hydroxyprogesterone haptensYOSHIDA, H; NAKAI, S; NIMBARI, F et al.Steroids. 1989, Vol 53, Num 6, pp 727-738, issn 0039-128X, 12 p.Article

Activité antiandrogène du chlormadinone acétateNOMURA, T.Yakuri to chiryo. 1988, Vol 16, Num 4, pp 279-282, issn 0386-3603Article

Ketoconazole in the treatment of acne in womenGHETTI, P; PATRONE, P; TOSTI, A et al.Archives of dermatology (1960). 1986, Vol 122, Num 6, issn 0003-987X, 629Article

Role of adrenal androgens in prostate regression in rats treated with an antiandrogen and an LHRH agonistFOLDESY, R. G; VANDERHOOF, M. M; CANTON, L. E et al.The Prostate. 1986, Vol 9, Num 3, pp 227-235, issn 0270-4137Article

The effect of spironolactone on hirsutism and female androgen metabolismDORRINGTON-WARD, P; MCCARTNEY, A. C. E; HOLLAND, S et al.Clinical endocrinology (Oxford. Print). 1985, Vol 23, Num 2, pp 161-167, issn 0300-0664Article

Antiandrogen therapy in dermatologySHAW, J. C.International journal of dermatology. 1996, Vol 35, Num 11, pp 770-778, issn 0011-9059Article

Pharmacodynamic modeling of finasteride, a 5α-reductase inhibitorKO, H. C; JUSKO, W. J.Pharmacotherapy. 1995, Vol 15, Num 4, pp 509-511, issn 0277-0008Article

Clinical profile of a new non-steroidal antiandrogenMAHLER, C; DENIS, L.Journal of steroid biochemistry and molecular biology. 1990, Vol 37, Num 6, pp 921-924, issn 0960-0760, 4 p.Conference Paper

Relative effectiveness of alternative androgen withdrawal therapies in initiating regression of rat prostateRENNIE, P. S; BRUCHOVSKY, N; GOLDENBERG, S. L et al.The Journal of urology. 1988, Vol 139, Num 6, pp 1337-1342, issn 0022-5347Article

Exposure to antiandrogen during pregnancy: case reportBERGH, T; BAKOS, O.British medical journal (1857). 1987, Vol 294, Num 6573, pp 677-678, issn 0007-1447Article

Pharmacodynamics and pharmacokinetics of bicalutamide : defining and active dosing regimenDENIS, L; MAHLER, C.Urology (Ridgewood, NJ). 1996, Vol 47, Num 1A, pp 26-28, issn 0090-4295, SUPConference Paper